ProCE Banner Activity

Keeping Up With the Treatment Landscape for MDD

Podcast Episodes

Listen as Clinical Care Options talks with Dr Anita Clayton about advances in treatment options for major depression, with a focus on modulators of glutamate and GABA.

Released: August 01, 2023

Share

Faculty

Anita H. Clayton

Anita H. Clayton, MD, DLFAPA, IF

Wilford W. Spradlin Professor and Chair
Department of Psychiatry & Neurobehavioral Sciences
Professor of Clinical Obstetrics & Gynecology
University of Virginia School of Medicine
Charlottesville, Virginia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sage Therapeutics, Inc. and Biogen.

Sage Therapeutics, Inc. and Biogen

Faculty Disclosure

Primary Author

Anita H. Clayton, MD, DLFAPA, IF

Wilford W. Spradlin Professor and Chair
Department of Psychiatry & Neurobehavioral Sciences
Professor of Clinical Obstetrics & Gynecology
University of Virginia School of Medicine
Charlottesville, Virginia

Anita H. Clayton, MD: researcher: Dare Bioscience, Janssen, Otsuka, Relmada Therapeutics, Sage Therapeutics; consultant/advisor/speaker: AbbVie, Biogen, Brii Biosciences, Fabre-Kramer, Initiator Pharma, Janssen, MindCure, Ovoca Bio, Praxis Precision Medicines, PureTech Health, Reunion Neuroscience, S1 Biopharma, Sage Therapeutics, Sertsei Pharmaceuticals, Takeda/Lundbeck, Vella Bioscience, WCG MedAvante-ProPhase; stock/stock options: Euthymics, Mediflix LLC, S1 Biopharma.